- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer risk in immune-mediated inflammatory diseases (IMID)
Authors
Keywords
Antirheumatic agents, Autoimmune diseases, Biological products, Cancer, Inflammation, Tumor necrosis factor
Journal
Molecular Cancer
Volume 12, Issue 1, Pages 98
Publisher
Springer Nature
Online
2013-08-30
DOI
10.1186/1476-4598-12-98
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and Marketed Proteasome Inhibitors for Cancer Treatment
- (2013) Jiankang Zhang et al. CURRENT MEDICINAL CHEMISTRY
- Differential Effects of Aspirin Before and After Diagnosis of Colorectal Cancer
- (2013) Boris Pasche JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
- (2012) MARK C. GENOVESE et al. JOURNAL OF RHEUMATOLOGY
- Aspirin and Cancer: Trials and Observational Studies
- (2012) J. A. Baron JNCI-Journal of the National Cancer Institute
- Daily Aspirin Use and Cancer Mortality in a Large US Cohort
- (2012) E. J. Jacobs et al. JNCI-Journal of the National Cancer Institute
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
- (2012) Guillaume Moulis et al. PLoS One
- Will an Aspirin a Day Keep Cancer Away?
- (2012) J. Kaiser SCIENCE
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
- (2011) X. Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Breast, ovarian and endometrial malignancies in systemic lupus erythematosus: a meta-analysis
- (2011) S Bernatsky et al. BRITISH JOURNAL OF CANCER
- Association between psoriasis and incident cancer: the Iowa’s Women’s Health Study
- (2011) Anna E. Prizment et al. CANCER CAUSES & CONTROL
- Polymorphisms of Tumor Necrosis Factor-Alpha and Hepatocellular Carcinoma Risk: A HuGE Systematic Review and Meta-Analysis
- (2011) Yonggang Wei et al. DIGESTIVE DISEASES AND SCIENCES
- Myeloid-derived suppressor cells: a double-edged sword?
- (2011) Agnieszka Pastuła et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Rituximab in rheumatoid arthritis and the risk of malignancies: Report from a French cohort
- (2011) Samy Slimani et al. JOINT BONE SPINE
- Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study
- (2011) Mashiko Setshedi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The risk of cancer in patients with psoriasis: A population-based cohort study in Taiwan
- (2011) Yi-Ju Chen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
- (2011) Erica D. Dommasch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diabetes and Pancreatic Cancer
- (2011) J. Trent Magruder et al. PANCREAS
- Tumor Necrosis Factor (TNF) and Lymphotoxin- (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
- (2010) C. F. Skibola et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies
- (2010) Natalia Pedersen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Systemic lupus erythematosus: Clinical presentations
- (2010) Paul P. Smith et al. AUTOIMMUNITY REVIEWS
- Skin cancers associated with autoimmune conditions among elderly adults
- (2010) E Lanoy et al. BRITISH JOURNAL OF CANCER
- Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans
- (2010) Annelie M. Landgren et al. CANCER
- Anti-inflammatory Agents: Present and Future
- (2010) Charles A. Dinarello CELL
- Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
- (2010) Peter C Taylor CURRENT OPINION IN PHARMACOLOGY
- Development of Hepatocellular Carcinoma in Autoimmune Hepatitis Patients: A Case Series
- (2010) Robert J. Wong et al. DIGESTIVE DISEASES AND SCIENCES
- Malignancies in Autoimmune Rheumatic Diseases – A Mini-Review
- (2010) Zoltán Szekanecz et al. GERONTOLOGY
- Autoimmunity and the risk of myeloproliferative neoplasms
- (2010) S. Y. Kristinsson et al. HAEMATOLOGICA
- The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis
- (2010) Yu Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
- (2010) Corrado Tarella et al. JOURNAL OF CLINICAL ONCOLOGY
- Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis
- (2010) Mike Georg Laukoetter et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pharmacologic Immunomodulation and Cutaneous Malignancy in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis
- (2010) M. S. KRATHEN et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab
- (2010) Adith Venkiteshwaran mAbs
- Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
- (2010) Johan Askling et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis
- (2010) Mona Gandhi et al. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
- Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance
- (2010) Tineke Cantaert et al. ARTHRITIS RESEARCH & THERAPY
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Malignancies in systemic lupus erythematosus
- (2009) Emese Kiss et al. AUTOIMMUNITY REVIEWS
- TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls
- (2009) Fang Fang et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden
- (2009) J Ji et al. BRITISH JOURNAL OF CANCER
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
- (2009) Millie D. Long et al. Clinical Gastroenterology and Hepatology
- Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies
- (2009) Luigi Naldi CLINICS IN DERMATOLOGY
- Inflammation and oncogenesis: a vicious connection
- (2009) Sergei I Grivennikov et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cancer in patients with ulcerative colitis, Crohnʼs disease and coeliac disease: record linkage study
- (2009) Michael J. Goldacre et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A cohort study of cancer among sarcoidosis patients
- (2009) Paolo Boffetta et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
- (2009) G. Solinas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Treatments for psoriasis and the risk of malignancy
- (2009) Rita V. Patel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis
- (2009) Takuya Watanabe et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long-term Follow-up of Cancer Risk in Patients Treated with Short-term Cyclosporine
- (2008) L Väkevä et al. ACTA DERMATO-VENEREOLOGICA
- Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients
- (2008) O. M. Martinez et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
- (2008) T Bongartz et al. ANNALS OF THE RHEUMATIC DISEASES
- Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
- (2008) T A Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate
- (2008) Rachelle Buchbinder et al. ARTHRITIS AND RHEUMATISM
- TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
- (2008) Nele Müller-Hermelink et al. CANCER CELL
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Corrupt policemen: inflammatory cells promote tumor angiogenesis
- (2008) Adrian Zumsteg et al. CURRENT OPINION IN ONCOLOGY
- Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis
- (2008) Jiyuan Zhang et al. JOURNAL OF HUMAN GENETICS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Abatacept in the treatment of rheumatoid arthritis
- (2008) Maya H Buch et al. ARTHRITIS RESEARCH & THERAPY
- TNFα blockade in human diseases: An overview of efficacy and safety
- (2007) Jan Lin et al. CLINICAL IMMUNOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More